Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
AXSM
#937
Axsome Therapeutics, Inc
188.990
0
USD
+2.61%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+2.61%
Monthly Change
+17.88%
6 month change
+45.15%
Year Change
+45.15%
Previous Close
184.190
0
Open
188.990
0
Bid
Ask
Low
188.990
0
High
188.990
0
Volume
182
Markets
US Stock Market
Healthcare
AXSM
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
48.77 M
49.24 M
49.9 M
50.41 M
51.15 M
—
Valuation ratios
Enterprise value
3.99 B
5.62 B
5.1 B
5.99 B
9.21 B
25.92 B
Price to earnings ratio
-14.13
-20.21
-20.59
-26.01
-49.63
-116.44
Price to sales ratio
10.51
13
10.26
10.64
14.23
48.13
Price to cash flow ratio
-31.57
-47.52
-42.14
-58.69
-97.27
-245.63
Price to book ratio
71.1
18.31
18.36
23.22
102.9
162.79
Enterprise value to EBITDA ratio
-14.9
-22.32
-23.81
-30.3
-58.77
-135.21
Profitability ratios
Return on assets %
-0.13
-0.1
-0.07
-0.07
-0.04
-0.29
Return on equity %
-1.31
-1.12
-0.66
-0.64
-0.32
-2.74
Return on invested capital %
-235.99
-174.38
-84.02
-83.1
-48.17
-389.67
Gross margin %
91.15
91.94
91.04
93.03
93.71
369.72
Operating margin %
-61.14
-46.91
-24.47
-26.97
-13.75
-112.1
EBITDA margin %
-54.44
-44.28
-22.67
-25.46
-10.08
-102.5
Net margin %
-63.08
-48.91
-31.97
-27.62
-14.57
-123.08
Liquidity ratios
Quick ratio
2.04
1.96
1.51
1.5
1.48
6.46
Current ratio
2.11
2.03
1.57
1.57
1.55
6.72
Inventory turnover
0.7
0.61
0.77
0.56
0.48
2.43
Asset turnover
0.21
0.21
0.24
0.26
0.29
1
Solvency ratios
Debt to assets ratio
0.32
0.31
0.3
0.28
0.28
1.16
Debt to equity ratio
3.19
3.44
2.59
2.58
2.16
10.77
Long term debt to total assets ratio
0.32
0.3
0.18
0.18
0.17
0.83
Long term debt to total equity ratio
3.17
3.41
1.61
1.6
1.33
7.95
Per share metrics
Operating cash flow per share
-0.55
-0.89
-0.66
0.02
-0.37
-1.9
EBIT per share
-1.52
-1.17
-0.74
-0.92
-0.54
-3.37
EBITDA per share
-1.35
-1.1
-0.69
-0.87
-0.4
-3.06
Total debt per share
3.8
3.75
3.83
3.8
3.83
15.21
Cash per share
6.58
6.16
6.13
6.5
6.49
25.28
Net current asset value per share
10.12
10.12
10.85
11.3
11.84
44.12
Tangible book value per share
-0.04
-0.09
0.35
0.39
0.72
1.37
Working capital per share
5.32
5.13
3.93
4.1
4.22
17.39
Book value per share
1.19
1.09
1.48
1.47
1.77
5.82
News
Four Biotech Stocks Near Buy Points As Earnings Season Kicks In
Biotech Stock Knocks At $2 Billion Opportunity, Nears Buy Point
ASML Stock, Astera Labs Among 15 New Stocks On IBD Watchlists
Cipher Mining Stock, Five Below, Indivior Among 10 New Stocks On IBD Watchlists
Axsome Therapeutics Priced For Perfection Ahead Of Auvelity's Alzheimer's Decision (AXSM)
Gold Stocks, AI Leader Broadcom Among 25 Newcomers To Best Stock Lists
Why Is Acadia (ACAD) Down 12.9% Since Last Earnings Report?
Neurocrine Biosciences: The Song Remains The Same (NASDAQ:NBIX)
AXSM's 2025 Revenue Surge Largely Driven by Auvelity: What's Ahead?
RBC Capital reiterates Axsome Therapeutics stock rating at Outperform
Axsome Therapeutics at The Citizens Life Sciences Conference: Strategic Growth Plans
Axsome Therapeutics, Inc. (AXSM) Presents at Leerink Global Healthcare Conference 2026 Transcript